News Category
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing value, including potential licensing, partnerships, ...
A new American Heart Association grant to Cedars-Sinai researchers will fund development of an AI-powered early warning system that combines wearable,...
SeABank's Sustainable Finance Framework, backed by an S&P Global Ratings second-party opinion, unifies green, blue, and social financing to accelerate...
Enodia Therapeutics has appointed Henrik Torp Nielsen as Chief Financial Officer to lead financial strategy as the company advances its proprietary Se...
Certified-PEP's 2026 comparison of 10 research peptide suppliers highlights the importance of batch-specific Certificates of Analysis and transparent ...
The Dr. Leonard Hochstein Grant recognizes its namesake's three-decade plastic surgery career, emphasizing his surgical volume, international patient ...
Hallstat's plan to relocate manufacturing for its CAUTI-reducing Foley catheter system to the U.S. or nearby countries aims to cut costs, shorten ship...
Creative Biolabs' tumor organoid co-culture models offer a more physiologically relevant 3D platform for evaluating CAR-T cell activity, addressing a ...
Creative Biolabs has introduced an integrated OMV and exosome-boosted CAR-T development platform to help researchers address poor infiltration, immuno...
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group, leading to a major board restructuring that could impact t...
Bronwyn Brophy O'Connor will become CEO of Carl Zeiss Meditec on December 1, 2026, bringing extensive medtech experience to drive innovation and trans...
Viromed Medical AG has completed a EUR 2 million capital increase to finance working capital, strengthening its financial position as it advances cold...
PolyPeptide shareholders approved a new board and removed takeover defenses, clearing the path for Samsung Biologics' tender offer and signaling a maj...
SS Innovations International showcased its SSi Mantra system and MantrAsana console in successful remote surgeries across 7,500 miles, highlighting th...
HeartBeam's acceptance into the FDA's TAP Pilot Program for its 3D ECG technology could expedite regulatory review and patient access to a potentially...
SS Innovations International showcased its SSi Mantra system and MantrAsana console in successful telesurgeries across two international conferences, ...
TransCode Therapeutics reported positive Phase 1a safety results for TTX-MC138 at ESMO Congress 2026, with no dose-limiting toxicities and early signs...
Oncotelic Therapeutics published a peer-reviewed study showing its PDAOAI platform identified a four-gene prognostic signature in liver cancer, a step...
Tonix Pharmaceuticals will report third-quarter 2026 financial results on Nov. 9, a disclosure that gives investors a timely look at the commercial ro...
RC Medical's venture studio builds new companies around physician-identified gaps in interventional radiology, an approach CEO David Ferrera says catc...
D. Boral Capital's Buy rating and $9 price target for QT Imaging highlight the market potential of its radiation-free Breast Acoustic CT scanner and f...
Coherence Neuro's $45 million Series A, backed by Peter Thiel and OpenAI, will fund a first chronic human trial of its SOMA implant for glioblastoma, ...
Adaptogenics Health Corp. is advancing a dual commercial and therapeutic strategy in the peptide sector, combining supply infrastructure, proprietary ...
VERAXA Biotech is implementing New Approach Methodologies across its preclinical oncology programs, aiming to improve clinical translation and reduce ...
VERAXA Biotech is advancing its BiTAC platform to create antibody-based cancer therapies that activate only when two targets are present on the same t...
Two peer-reviewed papers show BV100 achieves high lung concentrations and has a manageable drug-interaction profile, bolstering its potential as a muc...
SS Innovations International (NASDAQ: SSII) has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using its SSi Man...
Regentis Biomaterials has achieved a 400% increase in manufacturing yield for its GelrinC cartilage implant following European regulatory approval, wh...
Quantum BioPharma's Unbuzzd alcohol recovery formulation gained mainstream attention through a Men's Fitness article that highlighted promising but li...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies across its preclinical programs, aiming to generate more human-relevant data and...
Dr. Mona Mofid's ninth San Diego Top Doctor award, alongside patient satisfaction honors and team recognition, underscores her two-decade leadership i...
A new study reveals that ISAba1-mediated amplification of the crp-osmC gene cluster enhances Acinetobacter baumannii host adaptation but reduces biofi...
The American Heart Association's 2026 Health Tech Competition finalists aim to overcome adoption barriers and transform cardiovascular and brain healt...
SS Innovations International has submitted its response to the FDA's request for additional information on its 510(k) submission for the SSi Mantra su...
NanoViricides' Phase IIA trial of NV-387 Oral Gummies for Ebola Bundibugyo virus marks a critical step for a broad-spectrum antiviral that could addre...
A UK study finding that clearing immune fog can stop lung cancer before diagnosis underscores the promise of cancer interception, a field gaining prom...
NextPlat Corp opens a new PharmcoRx community pharmacy in Jacksonville, Florida, expanding its healthcare operations and targeting higher-margin contr...
Scinai Immunotherapeutics' CDMO subsidiary secured a $5.1 million development and clinical manufacturing agreement with a U.S. Nasdaq-listed biopharma...
Earth Science Tech Inc. is building a scalable healthcare business through vertical integration and a dual B2B/B2C model, with plans to expand its geo...
New research presented at the American Heart Association's Hypertension Scientific Sessions 2026 shows that masked hypertension—normal office blood pr...
Samsung's projected nine-fold profit increase to $80 billion highlights the explosive demand for AI memory chips and its ripple effects across the sem...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's clinical research business to execute a Phase 2 trial of Lucid-MS, a nove...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies across its preclinical programs, potentially accelerating clinical advancement, ...
SS Innovations International is advancing telerobotic surgery with its SSi Mantra system, reporting 195 telesurgeries and a 45% increase in installed ...
Lantern Pharma's Taiwan regulatory and IRB approvals for the Phase 2 HARMONIC trial of LP-300 enable expansion of a biomarker-driven study targeting E...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business to launch a Phase 2 trial of Lucid-MS signals a potential paradigm shift...
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies to reduce animal testing, accelerate clinical advancement, and cu...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business marks a critical step toward testing a first-in-class neuroprotective th...
